We are live on
!
Find out more
William Blair & Company Portfolio holdings
AUM
$34.9B
1-Year Est. Return
18.88%
This Fund
S&P 500
This Quarter
Est. Return
+7.16%
1 Year Est. Return
+18.88%
3 Year Est. Return
+73.84%
5 Year Est. Return
+90.13%
10 Year Est. Return
+563.35%
AUM
$34.1B
AUM Growth
+$1.63B
(+5%)
Cap. Flow
-$169M
Cap. Flow
% of AUM
-0.5%
Top 10 Holdings %
Top 10 Hldgs %
23.77%
Holding
1,892
New
86
Increased
671
Reduced
778
Closed
71
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$92.1M |
| 2 |
Aaon
AAON
|
+$55.5M |
| 3 |
P
Everpure Inc
P
|
+$43.5M |
| 4 |
Booz Allen Hamilton
BAH
|
+$29M |
| 5 |
RBC Bearings
RBC
|
+$26.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DexCom
DXCM
|
+$128M |
| 2 |
CrowdStrike
CRWD
|
+$42.9M |
| 3 |
Blackrock
BLK
|
+$42M |
| 4 |
CoStar Group
CSGP
|
+$41.5M |
| 5 |
Starbucks
SBUX
|
+$38.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.11% |
| 2 | Healthcare | 14.76% |
| 3 | Financials | 12.67% |
| 4 | Industrials | 11.93% |
| 5 | Consumer Discretionary | 7.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Krystal Biotech
KRYS
$9.66B
| $1.01M | ﹤0.01% |
5,568
+2
| +0% | +$386 |
|
902
Yum China
YUMC
$16.3B
| $1.01M | ﹤0.01% |
22,506
-3,133
| -12% | -$104K |
|
903
iShares 0-1 Year Treasury Bond ETF
SHV
$20.6B
| $1.01M | ﹤0.01% |
9,120
+810
| +10% | +$89.4K |
|
904
Delta Air Lines
DAL
$60.1B
| $1M | ﹤0.01% |
19,782
-35,717
| -64% | -$1.56M |
|
905
EXL Service
EXLS
$5.29B
| $1M | ﹤0.01% |
26,300
+6,611
| +34% | +$231K |
|
906
Viper Energy
VNOM
$14.7B
| $997K | ﹤0.01% |
22,100
| – | – |
|
|
CCRN
907
DELISTED
Cross Country Healthcare
CCRN
| $992K | ﹤0.01% |
73,794
-1,569
| -2% | -$23.1K |
|
908
Hyatt Hotels
H
$16.7B
| $990K | ﹤0.01% |
6,503
+4,812
| +285% | +$710K |
|
909
HubSpot
HUBS
$10.5B
| $989K | ﹤0.01% |
1,860
-135
| -7% | -$67.8K |
|
910
Uranium Energy
UEC
$5.57B
| $987K | ﹤0.01% |
159,000
-10,000
| -6% | -$54.3K |
|
911
Vanguard S&P 500 Growth ETF
VOOG
$27.3B
| $979K | ﹤0.01% |
17,016
-1,044
| -6% | -$57.9K |
|
912
Invesco S&P SmallCap Energy ETF
PSCE
$97.7M
| $978K | ﹤0.01% |
19,927
+1,754
| +10% | +$90.3K |
|
913
Solventum
SOLV
$14.1B
| $967K | ﹤0.01% |
13,867
-2,714
| -16% | -$163K |
|
914
HDFC Bank
HDB
$121B
| $960K | ﹤0.01% |
30,682
-1,212
| -4% | -$37.2K |
|
915
IQVIA
IQV
$39.3B
| $958K | ﹤0.01% |
4,043
-29
| -0.7% | -$6.84K |
|
916
Public Storage
PSA
$61.3B
| $952K | ﹤0.01% |
2,617
-269
| -9% | -$87.3K |
|
917
GSK
GSK
$106B
| $952K | ﹤0.01% |
23,290
-252
| -1% | -$10.3K |
|
|
AMTM
918
Amentum Holdings
AMTM
$6.05B
| $949K | ﹤0.01% |
+29,437
| New | +$839K |
|
|
SEE
919
DELISTED
Sealed Air
SEE
| $941K | ﹤0.01% |
25,934
-120,995
| -82% | -$4.23M |
|
920
Agilon Health
AGL
$1.6B
| $941K | ﹤0.01% |
9,574
+332
| +4% | +$42.9K |
|
921
Essential Utilities
WTRG
$11.4B
| $940K | ﹤0.01% |
24,367
-996
| -4% | -$39.1K |
|
922
Trade Desk
TTD
$6.49B
| $929K | ﹤0.01% |
8,476
-5,222
| -38% | -$521K |
|
923
Ligand Pharmaceuticals
LGND
$6.36B
| $922K | ﹤0.01% |
9,215
+80
| +0.9% | +$8.05K |
|
924
BHP
BHP
$230B
| $921K | ﹤0.01% |
14,835
+2,462
| +20% | +$136K |
|
925
First US Bancshares
FUSB
$90.8M
| $917K | ﹤0.01% |
83,000
| – | – |
|
Similar funds
SAM
VIA
William Blair & Company's Q3 2024 Portfolio in Review
As of Q3 2024, William Blair & Company held 1,892 positions worth $34.1B, up 5% from $32.4B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
William Blair & Company's Q3 2024 filing shows 86 new, 671 increased, 778 reduced and 71 closed positions. Its largest new stake was PAR Technology: 73,733 shares worth $3.84M. The largest sale was DexCom, an estimated $128M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.
- William Blair & Company's largest Q3 2024 buy was PAR Technology: 73,733 shares worth $3.84M.
- William Blair & Company added most to NVIDIA in Q3 2024, an estimated $92.1M increase.
- William Blair & Company's biggest Q3 2024 reduction was DexCom, cutting an estimated $128M.
- William Blair & Company fully exited Blackrock in Q3 2024, selling an estimated $42M.
- William Blair & Company's ten largest holdings make up 24% of its $34.1B portfolio in Q3 2024.
- William Blair & Company opened 86 new positions and closed 71 in Q3 2024.
- William Blair & Company's portfolio value rose 5% quarter-over-quarter to $34.1B.
Based on William Blair & Company's 13F filing for Q3 2024, filed 12 Nov 2024.